Influenza Treatment Guidelines
Introduction
- Influenza treatment guidelines are established by various medical societies, including the Infectious Diseases Society of America (IDSA), Centers for Disease Control and Prevention (CDC), American Thoracic Society, and British Thoracic Society, to provide evidence-based recommendations for the management of influenza 1, 2, 3, 4
Dosing and Administration
- The recommended dosing for adults and children over 24kg is 75 mg twice daily for 5 days, with reduced doses for children under 15kg and those with creatinine clearance less than 30 ml/min, as recommended by the guideline society 3
- Recommended treatment regimens include:
Benefits and Contraindications
- Early treatment with antivirals can reduce illness duration by approximately 24 hours, reduce hospitalization rates, and decrease subsequent antibiotic use, according to the guideline society 3
- Antibiotics should not be routinely prescribed for uncomplicated influenza without evidence of bacterial co-infection, as stated by the guideline society, with a strength of evidence not specified 3
- Antiviral treatment is recommended for high-risk individuals, including children under 2 years, adults over 65 years, persons with chronic medical conditions, immunocompromised individuals, and pregnant women, as recommended by the CDC 2
Patient Assessment and Antibiotic Use
- Patients with significant worsening of symptoms, COPD, or other severe pre-existing illnesses, and those with signs of pneumonia, should be considered for antibiotic treatment, as recommended by the guideline society 3
- First-line antibiotics for influenza treatment are Co-amoxiclav or doxycycline, with alternative options including Clarithromycin or erythromycin, according to the guideline society 3
- Evaluate illness severity based on vital signs, presence of respiratory distress, hydration status, mental status, and risk factors for complications, as recommended by the British Thoracic Society 3
- Monitor vital signs, including temperature, respiratory rate, heart rate, blood pressure, and oxygen saturation, at least twice daily, as recommended by the American College of Chest Physicians 3, 4
Diagnostic Testing
- Use diagnostic testing to confirm the specific viral pathogen, including rapid influenza testing for suspected influenza, PCR testing of respiratory specimens for SARS-CoV-2, and viral cultures to determine influenza subtype 9, 10
Perform the following diagnostic tests as indicated:
Test Indication Chest X-ray Respiratory symptoms present Blood cultures Severe illness suspected Sputum Gram stain and culture Productive cough present
Severe Disease Indicators
- Indicators of severe disease requiring hospital referral include respiratory distress, hypoxemia, rising respiratory and pulse rate, and altered mental status, as identified by the guideline society, with a strength of evidence not specified 4
- Clinical improvement can be assessed by temperature below 37.8°C for at least 24 hours, heart rate below 100/min, respiratory rate below 24/min, systolic blood pressure above 90 mmHg, and oxygen saturation above 90%, as indicated by the American Thoracic Society 3
Management and Treatment
- Maintain adequate hydration, provide supplemental oxygen as needed for hypoxemia, and consider acetaminophen for fever and symptom relief as an adjunct to oseltamivir, as recommended by the American Thoracic Society 3
- Patients should complete the full 5-day course of antiviral treatment, and monitoring for resolution of fever and improvement of symptoms is recommended, as well as watching for potential bacterial co-infection 1
- Review patients 24 hours prior to discharge and do not discharge patients with two or more of the following: temperature >37.8°C, heart rate >100/min, respiratory rate >24/min, systolic blood pressure <90 mmHg, oxygen saturation <90%, inability to maintain oral intake, or abnormal mental status, as recommended by the Journal of Infection and the Thorax guideline 4, 3
Patient Education and Follow-up
- Instruct patients to rest and limit activities until fever resolves, maintain adequate fluid intake, take antipyretics as directed for fever and pain, and avoid smoking and alcohol, as recommended by the British Thoracic Society 3
- Advise patients to return if they experience difficulty breathing or shortness of breath, pain or pressure in chest or abdomen, sudden dizziness or confusion, severe or persistent vomiting, or symptoms that improve but then return with fever and worse cough, as recommended by the British Thoracic Society 3
- Arrange follow-up for patients with significant complications, worsening of underlying disease, or high-risk conditions, as recommended by the Infectious Diseases Society 4
Prevention and Prophylaxis
- Consider prophylaxis for unvaccinated healthcare personnel in contact with influenza patients, all healthcare personnel if outbreak is caused by a variant not well-matched by vaccine, and high-risk patients exposed to influenza 9, 11
- Oseltamivir is approved for chemoprophylaxis in persons ≥13 years 11
- Restrict visitors with influenza-like illness during outbreaks, and evaluate healthcare personnel with influenza-like illness for removal from direct patient contact during outbreaks, as recommended by the American Thoracic Society 9